Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

XR-9576 enters clinical testing

May 12, 1998

Zadaxin decreases formation of lung tumors in mice

May 12, 1998

IntraDose injectable gel shows promise in phase I/II

May 12, 1998

Resveratrol has a direct antiproliferative effect against breast cancer cells

May 12, 1998

New chemotherapeutic agent targets sst receptor-expressing cancers

May 11, 1998

Cell Therapeutics plans phase II trials for CT-2584

May 11, 1998

Magainin updates status of squalamine program

May 11, 1998

Myriad Genetics awarded fourth patent covering the BRCA1 gene

May 11, 1998

Clotrimazole derivatives in preclinical testing at Imutec

May 11, 1998

Myriad Genetics enters into agreement with Rockefeller University for cancer gene research

May 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...